Author

T. Fukumoto

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

A. Yoshioka· 1 shared C. Y.-L. Chung· 1 shared H. Jimbo· 1 shared H. Tanizawa· 1 shared J. Sugita· 1 shared K. Hayasaka· 1 shared K. Kamada· 1 shared K. Sato· 1 shared

Activity by Year

2020-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Yoshioka

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Chemo-senolytic therapeutic potential against angiosarcoma

X. Wang, C. Y.-L. Chung, A. Yoshioka, S. Hashimoto, H. Jimbo, H. Tanizawa, S. Ohta, T. Fukumoto, K.-i. Noma

This study explores combining cisplatin and the senolytic agent ABT-263 to treat angiosarcoma, showing that low-dose cisplatin induces senescence, which is then eliminated by ABT-263, reducing chemotherapy side effects.

bioRxiv · Oct 19, 2023Cancer Biology

Efficacy of a novel SARS-CoV-2 detection kit without RNA extraction and purification

T. Fukumoto, S. Iwasaki, K. Hayasaka, K. Sato, S. Oguri, K. Taki, S. Nakakubo, K. Kamada, Y. Yamashita, S. Konno, M. Nishida, J. Sugita, T. Teshima

This study evaluates a new SARS-CoV-2 detection kit that skips RNA extraction and purification, showing high concordance with direct PCR across multiple sample types.

bioRxiv · May 27, 2020Microbiology